ASAP — Asarina Pharma AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK1.09m
- -SEK1.07m
Annual cashflow statement for Asarina Pharma AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -81 | -81.4 | -38.3 | -14.7 | -14.6 |
| Depreciation | |||||
| Non-Cash Items | 0 | — | — | — | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 19.5 | 2.25 | -4.6 | 4.96 | 2.94 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -61.5 | -79.1 | -42.5 | -9.32 | -11.3 |
| Capital Expenditures | -1.77 | -0.218 | 0 | 0 | 0 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -1.77 | -0.218 | 0 | 0 | 0 |
| Financing Cash Flow Items | -3.07 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 51.2 | 8.39 | 5.67 | 0.544 | 1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -12 | -71 | -36.8 | -8.14 | -10.4 |